These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 19100474

  • 1. Costimulation blockade of CD40 and CD28 pathways in limb transplantation.
    Tung TH, Mackinnon SE, Mohanakumar T.
    Transplant Proc; 2008 Dec; 40(10):3723-4. PubMed ID: 19100474
    [Abstract] [Full Text] [Related]

  • 2. Long-term limb allograft survival using anti-CD40L antibody in a murine model.
    Tung TH, Mackinnon SE, Mohanakumar T.
    Transplantation; 2003 Mar 15; 75(5):644-50. PubMed ID: 12640303
    [Abstract] [Full Text] [Related]

  • 3. Prolonged limb allograft survival with CD 40 costimulation blockade, T-cell depletion, and megadose donor bone-marrow transfusion.
    Tung TH, Mackinnon SE, Mohanakumar T.
    Microsurgery; 2005 Mar 15; 25(8):624-31. PubMed ID: 16281278
    [Abstract] [Full Text] [Related]

  • 4. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo.
    Cai Y, Zhou PJ, Tang XD.
    Chin Med J (Engl); 2004 Aug 15; 117(8):1178-83. PubMed ID: 15361291
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
    Habiro K, Kotani M, Omoto K, Kobayashi S, Tanabe K, Shimmura H, Suzuki K, Hayashi T, Toma H, Abe R.
    Transplantation; 2003 Sep 15; 76(5):854-8. PubMed ID: 14501867
    [Abstract] [Full Text] [Related]

  • 6. Long-term limb allograft survival using a short course of anti-CD45RB monoclonal antibody, LF 15-0195, and rapamycin in a mouse model.
    Zhong T, Liu Y, Jiang J, Wang H, Temple CL, Sun H, Garcia B, Zhong R, Ross DC.
    Transplantation; 2007 Dec 27; 84(12):1636-43. PubMed ID: 18165776
    [Abstract] [Full Text] [Related]

  • 7. Short-term anti-CD40 ligand costimulatory blockade induces tolerance to peripheral nerve allografts, resulting in improved skeletal muscle function.
    Brown DL, Bishop DK, Wood SY, Cederna PS.
    Plast Reconstr Surg; 2006 Jun 27; 117(7):2250-8. PubMed ID: 16772925
    [Abstract] [Full Text] [Related]

  • 8. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway.
    Uchida N, Shirasugi N, Akiyama Y, Matsumoto K, Shimazu M, Kitajima M, Hamano K, Aramaki O, Ikeda Y, Niimi M.
    Transplantation; 2003 Mar 27; 75(6):878-84. PubMed ID: 12660518
    [Abstract] [Full Text] [Related]

  • 9. Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination.
    Wang J, Zhang L, Tang J, Jiang S, Wang X.
    Transplant Proc; 2008 Jun 27; 40(5):1612-7. PubMed ID: 18589160
    [Abstract] [Full Text] [Related]

  • 10. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection.
    Ozkaynak E, Gao W, Shemmeri N, Wang C, Gutierrez-Ramos JC, Amaral J, Qin S, Rottman JB, Coyle AJ, Hancock WW.
    Nat Immunol; 2001 Jul 27; 2(7):591-6. PubMed ID: 11429542
    [Abstract] [Full Text] [Related]

  • 11. The CD28 peptidemimic can induce mixed chimerism and prolong the survival of cardiac allografts.
    Chen J, He Q, Xu H, Su L, Zhang J, Xiong S.
    Transpl Immunol; 2004 Dec 27; 13(4):283-8. PubMed ID: 15589741
    [Abstract] [Full Text] [Related]

  • 12. Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection.
    Trambley J, Bingaman AW, Lin A, Elwood ET, Waitze SY, Ha J, Durham MM, Corbascio M, Cowan SR, Pearson TC, Larsen CP.
    J Clin Invest; 1999 Dec 27; 104(12):1715-22. PubMed ID: 10606625
    [Abstract] [Full Text] [Related]

  • 13. Blockade of LIGHT/HVEM and B7/CD28 signaling facilitates long-term islet graft survival with development of allospecific tolerance.
    Fan K, Wang H, Wei H, Zhou Q, Kou G, Hou S, Qian W, Dai J, Li B, Zhang Y, Zhu T, Guo Y.
    Transplantation; 2007 Sep 27; 84(6):746-54. PubMed ID: 17893608
    [Abstract] [Full Text] [Related]

  • 14. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.
    Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC.
    Nature; 1996 May 30; 381(6581):434-8. PubMed ID: 8632801
    [Abstract] [Full Text] [Related]

  • 15. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways.
    Konieczny BT, Dai Z, Elwood ET, Saleem S, Linsley PS, Baddoura FK, Larsen CP, Pearson TC, Lakkis FG.
    J Immunol; 1998 Mar 01; 160(5):2059-64. PubMed ID: 9498741
    [Abstract] [Full Text] [Related]

  • 16. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA, Hancock WW, Luo B, Schur CD, Pawlick RL, Zhu LF, Anderson CC, Shapiro AM.
    Diabetes; 2006 Jan 01; 55(1):27-33. PubMed ID: 16380473
    [Abstract] [Full Text] [Related]

  • 17. Role of thymus in operational tolerance induction in limb allograft transplant model.
    Siemionow M, Izycki D, Ozer K, Ozmen S, Klimczak A.
    Transplantation; 2006 Jun 15; 81(11):1568-76. PubMed ID: 16770246
    [Abstract] [Full Text] [Related]

  • 18. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo.
    Kishimoto K, Dong VM, Issazadeh S, Fedoseyeva EV, Waaga AM, Yamada A, Sho M, Benichou G, Auchincloss H, Grusby MJ, Khoury SJ, Sayegh MH.
    J Clin Invest; 2000 Jul 15; 106(1):63-72. PubMed ID: 10880049
    [Abstract] [Full Text] [Related]

  • 19. Co-stimulation blockade targeting CD154 and CD28/B7 modulates the induced antibody response after a pig-to-baboon cardiac xenograft.
    Wu G, Pfeiffer S, Schröder C, Zhang T, Nguyen BN, Lea W, Kelishadi S, Atkinson JB, Schuurman HJ, White DJ, Azimzadeh AM, Pierson RN.
    Xenotransplantation; 2005 May 15; 12(3):197-208. PubMed ID: 15807770
    [Abstract] [Full Text] [Related]

  • 20. Neutralizing interleukin-4 prevents transplant arteriosclerosis mediated by indirect pathway T cells under CD40-CD154 costimulation blockade.
    Spriewald BM, Ensminger SM, Bushell A, Wood KJ.
    Transplantation; 2008 Dec 15; 86(11):1615-21. PubMed ID: 19077898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.